HomeCYCN • NASDAQ
add
Cyclerion Therapeutics Inc
Previous close
$3.10
Day range
$2.93 - $3.19
Year range
$1.27 - $9.47
Market cap
10.00M USD
Avg Volume
18.23K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 81.00K | — |
Operating expense | 1.54M | -4.94% |
Net income | -1.43M | 7.33% |
Net profit margin | -1.76K | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.64M | -36.11% |
Total assets | 9.85M | -13.35% |
Total liabilities | 1.07M | -25.95% |
Total equity | 8.78M | — |
Shares outstanding | 3.21M | — |
Price to book | 1.08 | — |
Return on assets | -37.51% | — |
Return on capital | -41.32% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.43M | 7.33% |
Cash from operations | -968.00K | 48.26% |
Cash from investing | — | — |
Cash from financing | 1.38M | — |
Net change in cash | 407.00K | 121.71% |
Free cash flow | -319.62K | 76.15% |
About
Founded
2018
Website
Employees
1
